All Stories

  1. Real-world anaplastic lymphoma kinase (ALK) rearrangement testing patterns, treatment sequences, and survival of ALK inhibitor-treated patients

    Article • Current Medical Research and Opinion, November 2018, Taylor & Francis

    Jessica Davies

  2. Comparative effectiveness from a single-arm trial and real-world data: alectinib versus ceritinib

    Article • Journal of Comparative Effectiveness Research, September 2018, Future Medicine

    Jessica Davies